I have said it all along. There are internal issues could be with investors or in the board and Dave took the fall.
If the FDA ok's the trial and in talks about the cpulse2.and surgeons backing the device and enrollments/centers should be up this quarter , basically things looking up , why the sudden change ?
The uncertainty wont help the stock price.
all the best.
SHC Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held